drugset / Trial / NCT04349371
Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The primary objective is to determine the clinical efficacy of Chloroquine (CQ) in health care workers with moderate to high risk of exposure to COVID-19 in preventing symptomatic COVID-19 infections. Secondary endpoints will explore the efficacy of CQ in preventing any infection as defined by seroconversion to positive anti-COVID antibody status.
Timeline
- Start
- 2020-04-21
- Primary completion
- 2021-02-11
- Completion
- 2021-02-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chloroquine | Small molecule | 250 mg | Oral |
| Subject | Chloroquine | Small molecule | 500 mg | Oral |